Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

Health News

Acorda shares plunge on negative FDA review

sfgate.com
Oct. 9, 2009
Shares of Acorda Therapeutics plummeted Friday after the Food and Drug Administration issued a negative opinion that questioned the safety and effectiveness of the company's multiple sclerosis drug. A panel of FDA advisers is scheduled to meet next week to...
Related Stories from UPI.com

Acorda says MS drug improves walking

HAWTHORNE, N.Y., Sept. 25 (UPI) -- U.S. firm Acorda Therapeutics said Monday it has seen positive results from a phase 3 study of Fampridine-SR for mulitple sclerosis (MS).

Acorda completes enrollment in MS trial

HAWTHORNE, N.Y., March 3 (UPI) -- Acorda Therapeutics said Friday it has completed enrollment in its phase 3 study of multiple sclerosis drug Fampridine SR.
Most Popular
Stories Photos People Comments
Featured Photos
1 of 23
Vietnam Veterans Memorial Commemorated in Washington
View Caption
A U.S. Air Force B-52 flies over the Vietnam Veterans Memorial during commemoration of 50th anniversary of the war on May 28, 2012 in Washington, DC. President Barack Obama is at the base of the wall left center. More than 58,000 names of the servicemen who were killed or missing in the war are engraved on The Wall. The B-52 bomber was used extensively during the Vietnam War. UPI/Pat Benic